Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 235.53 | 224.18 | 269.96 | 369.01 |
Depreciation/ Depletion | 51.45 | 50.32 | 50.05 | 49.88 |
Non- Cash Items | 31.56 | 34.83 | 20.36 | 18.72 |
Changesin Working Capital | 40.38 | -175.13 | -270.73 | -282.67 |
Cashfrom Operating Activities | 358.92 | 134.20 | 69.64 | 154.95 |
Capital Expenditures | -226.33 | -164.82 | -151.97 | -88.23 |
Other Investing Cash Flow Items Total | 2.68 | 0.85 | 3.11 | 16.45 |
Cashfrom Investing Activities | -223.65 | -163.97 | -148.86 | -71.78 |
Financing Cash Flow Items | -44.63 | -36.19 | -34.42 | -22.96 |
Total Cash Dividends Paid | -9.27 | -9.40 | -9.51 | -23.21 |
Issuance( Retirement)of Stock Net | -59.85 | 0.76 | -60.00 | 0.00 |
Issuance( Retirement)of Debt Net | -22.28 | 61.37 | 195.95 | -34.97 |
Cashfrom Financing Activities | -136.03 | 16.54 | 92.03 | -81.13 |
Net Changein Cash | -0.76 | -13.23 | 12.80 | 2.04 |
Cash Interest Paid | 31.31 | 36.19 | 20.58 | 22.96 |
Cash Taxes Paid | 62.40 | 59.67 | 83.38 | 96.68 |
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Profit Loss Aarti Drugs Balance Sheet Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks